Department of Health and Social Care written question – answered at on 20 January 2026.
Seamus Logan
Shadow SNP Spokesperson (Health and Social Care), Shadow SNP Spokesperson (Environment, Food and Rural Affairs)
To ask the Secretary of State for Health and Social Care, if he will publish impact assessments, modelling and further detail on the UK-US pharmaceutical trade deal.
Zubir Ahmed
The Parliamentary Under-Secretary for Health and Social Care
Tens of thousands of National Health Service patients will benefit from this deal, which will secure and expand access to vital drugs, and thereby safeguard our medicines supply chain.
Costs will start smaller but will increase over time as the National Institute for Health and Care Excellence (NICE) approves more life improving and lifesaving medicines. Total costs over the Spending Review period are expected to be approximately £1 billion. The final costs will depend on which medicines NICE recommends and the actual uptake of these.
This deal is a vital investment that builds on the strength of our NHS and world leading life sciences without taking essential funding from our frontline NHS services.
There are no current plans to publish an impact assessment or modelling on the United Kingdom and United States’ pharmaceutical trade deal. Further detail on the deal will be shared in due course.
Yes1 person thinks so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
Secretary of State was originally the title given to the two officials who conducted the Royal Correspondence under Elizabeth I. Now it is the title held by some of the more important Government Ministers, for example the Secretary of State for Foreign Affairs.
